🟢 Kailera Therapeutics is trading 6.3% up today with no verified company-specific catalyst identified

Kailera Therapeutics is trading 6.3% up at $12.74, with no verified company-specific catalyst identified for September 22, 2026.

• The latest company announcement concerns investor conferences scheduled for September 23 and September 30, not a new operational or clinical disclosure.
• Broader markets are modestly positive: the S&P 500 is up 0.13% and the Nasdaq 0.40%, insufficient to clearly explain the move.
• The reason for the move remains uncertain.